我要投票 Osteoform乐力在补钙行业中的票数:598
· 外 推 电 报 ·
2025-09-09 16:41:50 星期二

【Osteoform乐力是哪个国家的品牌?】

Osteoform乐力是什么牌子?「Osteoform乐力」是维奥健康科技(成都)有限公司旗下著名品牌。该品牌发源于四川,由创始人薛洋在2011期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Osteoform乐力品牌出海!将品牌入驻外推网,定制Osteoform乐力品牌推广信息,可以显著提高Osteoform乐力产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

“乐力”这一国人家喻户晓的补钙产品品牌,今后将逐渐拓展成为一个基本涵养人体健康、保健营养补充的“大”健康品牌。

乐力氨基酸螯合钙(Osteoform)于1997年进入中国市场以来,一起以先进的技术、专业的品质与优质的服务专注于国人营养健康,这也是乐力品牌获得消费者信赖的关键所在。

乐力氨基酸螯合钙(Osteoform)用于防治钙、矿物质缺乏引起的各种疾病,尤适用于骨质疏松、儿童佝偻病、缺钙引起的神经痛、肌肉抽搐等。也可用作孕期、哺乳期妇女和儿童的钙和维生素D3的补充。

乐力氨基酸螯合钙(Osteoform)的原料来自美国矿维公司,符合美国FDA及美国政府颁布的《人体摄取维生素和矿物质标准》严格要求,特有的螯合技术带来卓越疗效。美国矿维公司授权GMP认证企业——四川维奥制药有限公司,对其生产的、原装进口大包装乐力复方氨基酸螯合钙胶囊进行分包装,并对分包装生产流程进行全过程的严格质量监控,确保了乐力复方氨基酸螯合钙胶囊继续保持其原装进口药品固有的优良品质。自1997年进入中国市场以来,累计用户超过5000万,未出现不良反应报道。

根据中华人民共和国药品通用名称命名原则,国家药典委员会发布药典业发[2003]第018号文正式命名乐力为复方氨基酸螯合钙胶囊。国家药监局国药监安〔2001〕254号文件公布的第二批国家乙类非处方药将乐力复方氨基酸螯合钙胶囊列入乙类非处方药(OTC),国家药监部门的行文也表明乐力胶囊的用药是安全可靠的。

乐力品牌大事记

1997年,美国矿维公司生产的“乐力复方氨基酸螯合钙”进入中国市场;

2003年,“乐力”参与由北京市西部阳光农村发展基金会发起的“西部阳光工程”,开始援助偏远地区建立希望小学;

2005年,中国家庭健康普及项目办公室授权“乐力社区健康教员”在全国妇联、卫生部批准的“百万家庭送健康——中国家庭健康普及项目”中以“中国家庭健康普及项目社区健康教员”身份独立开展社区健康教育工作,并接受“中国家庭健康普及项目办公室”的监督;

2005年,《乐力健身操》作为“乐力健康计划项目暨成都体育学院全民健身课题”项目荣获国家体育总局授予的优秀全民健身项目一等奖;

2006年,中国非处方药物协会自我药疗教育专业委员会2006年度中国家庭常备用药调查结果,家庭常备的维生素类和钙制剂前三位依次为21金维他、乐力和金施尔康,分别占42.2%、29.7%和29.4%;

2007年,“乐力”入选中国品牌100强;被国家公众营养与发展中心授予“营养健康倡导产品”;

2002-2008年,《中国药店》连续五年授予“乐力”胶囊“店员推荐率最高品牌”;

2009年,顺应中国消费者“预防胜于治疗,防病重于治病”的健康理念,“乐力”推出膳食营养补充剂产品“乐力复合氨基酸螯合胶囊”,旨在提高机体健康水平和降低疾病发生风险;

2010年,“乐力LEMERRY”系列美国原装进口膳食营养补充剂面世,通过调整人们饮食中各项营养元素或生物活性物质的摄入量,倡导健康的生活方式;

2013年,“乐力牌多种矿物质维生素D胶囊”(国食健字G20130583,武汉维奥制药有限公司生产)获得国家食品药品监督管理总局“保健食品批准证书”,用于补充钙,镁,锌,锰,铜和维生素D等矿物质营养元素;

2014年,美国原装进口“乐力复合氨基酸螯合胶囊”进行了“新配方,新工艺”的改造,并通过国家《运动营养食品通则》标准审核,用于满足人体运动的基本营养需求;

“乐力”品牌钙制剂产品作为重点推荐产品载入高等院校教材《妇产科学》第七版、《妇科常见病症用药指南》、《儿科学新进展》、《骨质疏松学》、《骨质疏松现代诊疗》等众多医学专著。

英文翻译:"Leli", a well-known brand of calcium supplement products in China, will gradually expand into a "big" health brand with basic health care and nutrition supplement. Since its entry into the Chinese market in 1997, Osteoform has been focusing on the nutrition and health of Chinese people with advanced technology, professional quality and high-quality service, which is also the key for the brand to win the trust of consumers. L-amino acid chelated calcium (Osteoform) is used to prevent and treat various diseases caused by calcium and mineral deficiency, especially for osteoporosis, rickets in children, neuralgia and muscle twitch caused by calcium deficiency. It can also be used as a supplement of calcium and vitamin D3 for pregnant and lactating women and children. The raw material of amino acid chelated calcium (Osteoform) comes from the US mining and maintenance company. It meets the strict requirements of the US FDA and the US government's "standards for human intake of vitamins and minerals". The unique chelating technology brings excellent curative effect. Sichuan Weiao Pharmaceutical Co., Ltd., a GMP certified enterprise authorized by us Mining & Maintenance Co., Ltd., repackages the original packaging of Leli compound amino acid calcium chelate capsules, and strictly monitors the quality of the whole process of repackaging production process to ensure that Leli compound amino acid calcium chelate capsules continue to maintain the inherent good quality of the original imported drugs. Since entering the Chinese market in 1997, the total number of users has exceeded 50 million, and no adverse reactions have been reported. According to the naming principle of the general name of drugs of the people's Republic of China, the National Pharmacopoeia Committee issued the Pharmacopoeia YF [2003] No.018 document to officially name Leli as the compound amino acid calcium chelate capsule. The second batch of national B-type over-the-counter drugs published by the State Food and Drug Administration (Gya [2001] No. 254) listed Leli compound calcium amino acid chelate capsule in the OTC. The documents issued by the State Food and drug administration also showed that Leli capsule was safe and reliable. In 1997, "Leli compound amino acid chelate calcium" produced by mining and maintenance company of the United States entered the Chinese market; in 2003, "Leli" participated in the "Western sunshine project" initiated by Beijing Western sunshine rural development foundation and began to assist remote areas to establish hope primary school; in 2005, China family health popularization Project Office authorized "Leli community health education" Member "carried out community health education independently as" community health teacher of China family health popularization project "in the" million families delivering health - China family health popularization project "approved by the all China Women's Federation and the Ministry of health, and accepted the supervision of" China family health popularization Project Office "; In 2005, Leli aerobics won the first prize of excellent national fitness program awarded by the State General Administration of sport as a project of Leli health program and national fitness program of Chengdu Institute of physical education; in 2006, the results of 2006 survey on Chinese family regular use of drugs by the self medication education professional committee of China over the counter drug association, The top three vitamins and calcium preparations in the family were 21 jinvita, Leli and jinshierkang, accounting for 42.2%, 29.7% and 29.4% respectively; in 2007, "Leli" was selected as one of the top 100 Chinese brands; it was awarded "nutrition and health advocacy products" by the National Center for public nutrition and development; in 2002-2008, "China Drugstore" awarded "Leli" capsule "the highest recommended rate of salesmen" for five consecutive years Brand); in 2009, in line with the health concept of "prevention is better than treatment, disease prevention is more important than treatment" of Chinese consumers, "Leli" launched "Leli compound amino acid chelate capsule" as a dietary supplement product, aiming to improve the health level of the body and reduce the risk of disease; in 2010, "Leli lemerry" series of imported dietary supplements from the United States were launched, through the adjustment of people In 2013, "Leli brand multi mineral vitamin D capsule" (produced by guoshijianzi g20130583, Wuhan vio Pharmaceutical Co., Ltd.) was awarded the "health food approval certificate" by the State Food and drug administration, which was used to supplement calcium, magnesium, zinc, manganese, copper and vitamin D, etc In 2014, the United States imported "Leli compound amino acid chelate capsule" for "new formula, new process" transformation, and through the national "general principles of sports nutrition food" standard audit, to meet the basic nutritional needs of human movement; As a key recommended product, "Leli" brand calcium preparation product has been included in many medical monographs, such as the seventh edition of Obstetrics and Gynecology textbook, drug guide for common gynecological diseases, new progress in pediatrics, osteoporosis, modern diagnosis and treatment of osteoporosis, etc.

本文链接: https://www.waitui.com/brand/59214d1f4.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

高测股份:已推出适用于人形机器人灵巧手的复合金属腱绳,并形成小批量订单

36氪获悉,高测股份公告,公司已成功推出适用于人形机器人灵巧手及其他部位的复合金属腱绳,并已形成小批量订单。针对灵巧手高自由度要求,公司主推复合钨丝腱绳,复合钨丝腱绳具备极小的折弯半径,独特分子结构设计具备更优耐磨及耐疲劳性能,能为人形机器人灵巧手绳驱方案提供更可靠、耐久且精准的动力传输和高自由度解决方案,受到客户高度认可,已进入多家机器人相关企业试用,并已与国内头部企业开展深入研发合作。

42分钟前

特斯拉推出升级版Megapack 3

周一,特斯拉在拉斯维加斯举行的“Las Megas”活动上发布了Megapack 3和Megablock,该公司表示,其升级版Megapack 3使用了“大幅简化的热舱,减少了78%的连接”,并表示将于2026年底在休斯顿生产。(新浪财经)

42分钟前

摩根士丹利:预计到2040年,中国药物将占美国FDA批准药物的35%

摩根士丹利近日发布深度研报称,预计到2040年,源自中国的药物在美国食品药品监督管理局(FDA)获批的比例将从目前的5%提升至35%,并将在中国以外市场创造约2200亿美元的收入。预计得益于中国在药物研发方面的速度和成本优势,到2040年全球研发回报率将提高48%。摩根士丹利还称,全球制药行业正面临一项迫在眉睫的挑战:到2035年,因专利到期(LOE)导致的收入损失预计将高达1150亿美元。(财联社)

42分钟前

动力新科:上海微电子借壳动力新科上市消息不实

36氪获悉,针对投资者关于“据消息称上海微电子正在策划借壳动力新科上市,这是巧合还是提前安排重组事宜?”的提问,动力新科在互动平台回应称,上述消息不实。

42分钟前

消息称英伟达要求三星翻倍供应GDDR7

据业内人士消息,英伟达已要求三星翻倍供应GDDR7,三星的扩产准备工作已基本完成,预计扩大后的供应链最早将于本月开始运营。据了解,英伟达要求三星提高GDDR7供应量,主要是为了AI加速器需求。 (财联社)

42分钟前

本页详细列出关于Osteoform乐力的品牌信息,含品牌所属公司介绍,Osteoform乐力所处行业的品牌地位及优势。
咨询